Clinical Trial Update: Double Blind Randomized Placebo Controlled Trial of Natrecor in Acute Decompensated Heart Failure With Normal EF [Phase 4]

View source ↗

Summary

A Phase 4, double-blind, randomized, placebo-controlled trial of nesiritide (Natrecor) in acute decompensated heart failure with normal ejection fraction was wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Pulmonary Edema

Drugs mentioned

• Natrecor (nesiritide)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Heart Failure, Congestive, Dyspnea | Phase 4 | Status: WITHDRAWN